U.S. regulators have accepted a new submission for Vyglxia, offering the chance at a turnaround for another rare disease ...
The notice adds to growing concerns about the safety of knockoff weight loss drugs, which have remained popular despite FDA ...
Lower-than-expected sales of Xolair stood out as the Swiss drugmaker readies for an onslaught of generic competition for top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results